ASO Author Reflections: 3-Year Survival Outcomes of Lymphadenectomy in Minimally Invasive Esophagectomy
- 26 June 2023
- journal article
- editorial
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 30 (11) , 6737-6738
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Three-Field Versus Two-Field Lymphadenectomy in Minimally Invasive Esophagectomy: 3-Year Survival Outcomes of a Randomized TrialAnnals of Surgical Oncology, 2023
- ASO Visual Abstract: Early Circulating Tumor DNA Dynamics Predict Neoadjuvant Therapy Response and Recurrence in Colorectal Liver Metastases—A Prospective StudyAnnals of Surgical Oncology, 2023
- Patterns of Recurrence and Long-Term Survival of Minimally Invasive Esophagectomy Versus Open Esophagectomy for Locally Advanced Esophageal Cancer Treated with Neoadjuvant Chemotherapy: a Propensity Score–Matched AnalysisJournal of Gastrointestinal Surgery, 2023
- Three-Field Lymphadenectomy in Minimally Invasive Esophagectomy for Squamous Cell CarcinomaThe Annals of Thoracic Surgery, 2021
- Long-term Survival After Minimally Invasive Versus Open Esophagectomy for Esophageal CancerAnnals of Surgery, 2020
- Esophagectomy With Three-Field Versus Two-Field Lymphadenectomy for Middle and Lower Thoracic Esophageal Cancer: Long-Term Outcomes of a Randomized Clinical TrialJournal of Thoracic Oncology, 2020
- Patterns of lymph node metastasis in 3-field dissection for carcinoma in the thoracic esophagusSurgery Today, 1994